Developing new methods to create important organic compounds for medicine
New Methods for Therapeutic Development
['FUNDING_OTHER'] · VANDERBILT UNIVERSITY · NIH-11011893
This study is exploring new ways to create special building blocks for medicines that can help improve drug development, which could lead to better treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY (nih funded) |
| Locations | 1 site (Nashville, UNITED STATES) |
| Trial ID | NIH-11011893 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative reactions and reagents to produce enantioenriched organic compounds, which are essential building blocks for developing small molecule therapeutics. By synthesizing specific types of amines and diamines as single stereoisomers, the project aims to enhance the efficiency of producing complex biologically active natural products. The approach involves using new catalysts and chiral proton complexes to improve the selectivity and effectiveness of these reactions. Patients may benefit from advancements in drug development stemming from these novel synthetic methods.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated by new small molecule therapeutics derived from the compounds being developed.
Not a fit: Patients with conditions that do not respond to small molecule therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted therapeutic agents for various medical conditions.
How similar studies have performed: Other research has shown success in developing new synthetic methods for small molecule therapeutics, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Nashville, UNITED STATES
- VANDERBILT UNIVERSITY — Nashville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JOHNSTON, JEFFREY NICHOLAS — VANDERBILT UNIVERSITY
- Study coordinator: JOHNSTON, JEFFREY NICHOLAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.